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changes in the number of cells that harbor nuclear -catenin or loss of E-cadherin, and to determine whether these changes are
associated with survival.
Methods and materials. Between January 2008 and December 2010, 98 patients with rectal adenocarcinoma stage T2 to T4 and/or
N1 to N2 were prospectively included. All patients were treated with pelvic RT (46–50Gy in 2Gy fractions) and intravenous 5-Fu in
continuous infusion (225mg/m2) or capecitabine (825mg/m2) during RT treatment followed by TME in 6 weeks. Tumor samples
were collected during diagnosis (pre-RT-CT) and during surgery (post-RT-CT) and inmunohistochemistry of nuclear -catenin and
membranous E-cadherin were performed. Univariate survival analysis for the outcome (disease-free survival) was conducted
based on Kaplan–Meier analysis. Multivariate survival analysis was conducted using a multivariate Cox regression model.
Results. Patients with an increase in the number of cells that expressed nuclear -catenin after RT-CT (49%) showed a median
survival of 37 months (11–63) vs. not reached for patients with decreased nuclear expression of -catenin (17%) (p=0.02). Postop-
erative lymph node metastases and T stage were found as independent, negative prognostic factors. Increased nuclear -catenin
expression after RT-CT barely missed the cutoff for signiﬁcance (p=0.06).
Conclusions. Preoperative RT-CT in LARC patients induces a signiﬁcant increase in the number of cells that express nuclear -
catenin, which confers a poorer prognosis. This ﬁnding must be conﬁrmed prospectively in clinical trials to identify a subgroup
of patients with more aggressive disease. Targeting of -catenin should be investigated.
http://dx.doi.org/10.1016/j.rpor.2013.03.852
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Background. Expression of intrinsic marker of tumor hypoxia (HIF 1), androgen receptor homeostasis (p21-activated kinase 6)
and protein degradation (PSMB4) have been shown to increase tumor cell death, enhance chemotherapy, and increase radiation
sensitivity in solid tumors.
Purpose. The present study analyzes the expression by immunochemistry of HIF 1, PAK-6 and PSMB4 and its correlationwith clin-
ical outcome, in men with localized prostate cancer (PC) treated with dose escalation radiotherapy (RT) and androgen deprivation
(AD).
Materials and methods. Between 1996 and 2003, a cohort of 129 PC patients who had diagnostic biopsies pre-treatment and 24–36
months following RT and for whom sufﬁcient diagnostic tissue for immunohistochemical staining was available, were enrolled
in this study. Median follow-up was 129 months (26–204). Suitable archival diagnostic tissue was obtained from 89 patients.
Correlation analysis was done to assess association between HIF 1, PAK-6 and PSMB4 expression and clinical outcome in terms
of local relapse, biochemical failure, distant metastasis, and overall survival.
Results. HIF 1, PAK-6 and PSMB4 were expressed in the cytoplasm in 29%, 62% and 96.7% respectively of diagnostic biopsies,
and in 36%, 47% and 85% of post-RT biopsies respectively. Increased staining for PAK-6 was signiﬁcantly (p=0.04) correlated with
higher Gleason scores. A borderline signiﬁcant relationship was observed between expression of cytoplasmic HIF 1 and overall
survival (p=0.08). In univariate and multivariate analyses, there was no statistically signiﬁcant relationship seen between PAK-6
and PSMB4 expression and outcome. There were not correlation in expression of the three biomarkers between diagnostic tissue
and post-treatment biopsies.
Conclusions. This is the ﬁrst description of PAK6 and PSMB4 expression in the diagnostic specimens of men with prostate cancer
treated with RT. PAK-6 expression was signiﬁcantly correlated with higher Gleason scores. PSMB4 expression was not related to
any of the outcome end points tested. The small cohort of patients could be responsible for the lack of signiﬁcant correlation
between HIF 1 and survival observed in other series.
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